After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Malema’s CIFM-88 Series Duramassflow PFA Coriolis industrial flow meter has been launched globally. The solution offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback